AbbVie Yönetim
Yönetim kriter kontrolleri 2/4
AbbVie's CEO is Robert Michael, appointed in Jul 2024, has a tenure of less than a year. total yearly compensation is $14.44M, comprised of 9.9% salary and 90.1% bonuses, including company stock and options. directly owns 0.006% of the company’s shares, worth $20.06M. The average tenure of the management team and the board of directors is 1.1 years and 11.8 years respectively.
Anahtar bilgiler
Robert Michael
İcra Kurulu Başkanı
US$14.4m
Toplam tazminat
| CEO maaş yüzdesi | 9.9% |
| CEO görev süresi | less than a year |
| CEO sahipliği | 0.006% |
| Yönetim ortalama görev süresi | 1.1yrs |
| Yönetim Kurulu ortalama görev süresi | 11.8yrs |
Son yönetim güncellemeleri
Recent updates
AbbVie: 3 Positives From The Earnings Report
Oct 30AbbVie: Strong Dividends But Humira Disappoints
Oct 22AbbVie: Dividend Discount Model Suggests Large Valuation Risks
Sep 29We Think AbbVie (NYSE:ABBV) Can Stay On Top Of Its Debt
Sep 06
Why AbbVie Remains One Of My Favorite Dividend Growers
Aug 27AbbVie: Growth Is Still A Better Choice
Jul 29AbbVie Q2 2024 Earnings Preview: Post Gonzalez Era Can Begin On Positive Note
Jul 17AbbVie: A Hold Again (Rating Downgrade)
Jul 03Earnings Tell The Story For AbbVie Inc. (NYSE:ABBV)
Jun 28AbbVie: 5 Reasons That Make A Buy Case
Jun 18Looking For Both Income And Growth? 4%-Yielding AbbVie Has You Covered
May 29Here's Why AbbVie (NYSE:ABBV) Can Manage Its Debt Responsibly
May 21CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$5b |
| Jun 30 2024 | n/a | n/a | US$5b |
| Mar 31 2024 | n/a | n/a | US$6b |
| Dec 31 2023 | US$14m | US$1m | US$5b |
| Sep 30 2023 | n/a | n/a | US$6b |
| Jun 30 2023 | n/a | n/a | US$9b |
| Mar 31 2023 | n/a | n/a | US$8b |
| Dec 31 2022 | US$10m | US$1m | US$12b |
| Sep 30 2022 | n/a | n/a | US$13b |
| Jun 30 2022 | n/a | n/a | US$13b |
| Mar 31 2022 | n/a | n/a | US$12b |
| Dec 31 2021 | US$12m | US$1m | US$11b |
| Sep 30 2021 | n/a | n/a | US$7b |
| Jun 30 2021 | n/a | n/a | US$7b |
| Mar 31 2021 | n/a | n/a | US$5b |
| Dec 31 2020 | US$13m | US$1m | US$5b |
| Sep 30 2020 | n/a | n/a | US$7b |
| Jun 30 2020 | n/a | n/a | US$7b |
| Mar 31 2020 | n/a | n/a | US$8b |
| Dec 31 2019 | US$9m | US$907k | US$8b |
| Sep 30 2019 | n/a | n/a | US$3b |
| Jun 30 2019 | n/a | n/a | US$4b |
| Mar 31 2019 | n/a | n/a | US$5b |
| Dec 31 2018 | US$3m | US$554k | US$6b |
Tazminat ve Piyasa: Robert's total compensation ($USD14.44M) is about average for companies of similar size in the US market ($USD12.87M).
Tazminat ve Kazançlar: Robert's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
CEO
Robert Michael (54 yo)
less than a year
Görev süresi
US$14,441,320
Tazminat
Mr. Robert A. Michael served as Chief Operating Officer at AbbVie Inc. since June 29, 2023 until July 01, 2024 and served as its President since June 23, 2022 until July 01, 2024 also serves as its CEO and...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Executive Chairman | 11.8yrs | US$25.66m | 0.022% $ 79.2m | |
| CEO & Director | less than a year | US$14.44m | 0.0056% $ 20.1m | |
| Executive VP & CFO | 2.4yrs | US$10.19m | 0.00087% $ 3.1m | |
| Executive VP & COO | less than a year | US$9.30m | 0.011% $ 40.8m | |
| Executive VP & Chief Commercial Officer | no data | US$15.35m | 0.0035% $ 12.7m | |
| Executive VP of Research and Development & Chief Scientific Officer | less than a year | Veri yok | 0.00093% $ 3.3m | |
| Senior Vice President of Investor Relations | no data | Veri yok | Veri yok | |
| Executive VP | 2.1yrs | Veri yok | 0% $ 0 | |
| Senior VP | 1.1yrs | Veri yok | Veri yok | |
| Executive VP & Chief Human Resources Officer | no data | US$3.30m | 0.00078% $ 2.8m | |
| Senior VP of AbbVie & President of Oncology | 1.1yrs | Veri yok | Veri yok | |
| Executive VP and Chief Business & Strategy Officer | 1.8yrs | Veri yok | 0.0032% $ 11.4m |
1.1yrs
Ortalama Görev Süresi
55yo
Ortalama Yaş
Deneyimli Yönetim: ABBV's management team is not considered experienced ( 1.1 years average tenure), which suggests a new team.
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Executive Chairman | 11.8yrs | US$25.66m | 0.022% $ 79.2m | |
| CEO & Director | less than a year | US$14.44m | 0.0056% $ 20.1m | |
| Lead Independent Director | 11.8yrs | US$388.39k | 0.00065% $ 2.3m | |
| Independent Director | 4.5yrs | US$389.98k | 0.0071% $ 25.5m | |
| Independent Director | 11.8yrs | US$421.58k | 0.0014% $ 5.1m | |
| Independent Director | 11.8yrs | US$394.98k | 0.00091% $ 3.3m | |
| Independent Director | 11.8yrs | US$377.48k | 0% $ 0 | |
| Independent Director | 11.8yrs | US$369.98k | 0.00011% $ 395.5k | |
| Independent Director | 7.5yrs | US$369.98k | 0% $ 0 | |
| Independent Director | 8.8yrs | US$384.98k | 0% $ 0 | |
| Independent Director | 6.5yrs | US$359.98k | Veri yok | |
| Independent Director | 11.8yrs | US$461.18k | 0.000010% $ 36.0k |
11.8yrs
Ortalama Görev Süresi
70yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: ABBV's board of directors are seasoned and experienced ( 11.8 years average tenure).